Document:

c58919_ex4-4.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing

Exhibit 4.4

 

WARRANT AGREEMENT 

  

  

  BETWEEN 

  

  BIOCUREX, INC. 

  

  AND 

  

  SECURITIES TRANSFER CORPORATION 

  

  

  DATED AS OF _____________, 2009 

 

 

 

 

 

WARRANT AGREEMENT

          This
Agreement is between BioCurex, Inc., f/k/a Whispering Oaks International, Inc.,
a Texas corporation (the “Company”)
and Securities Transfer Corporation, a _______ corporation (the “Warrant Agent”). 

          The Company, at or about the time that it is entering into this Agreement, proposes to issue and sell to public investors up to 1,380,000 Units (together with the additional units issuable as
provided herein, the “Units”). Each Unit consists of 70 shares of the Company’s (i) common stock, $0.001 par value (the “Common Stock”), and (ii) 70 redeemable warrants (the “Unit Warrants”).  Each Unit Warrant is exercisable to
purchase one share of Common Stock upon the terms and conditions and subject to adjustment in certain circumstances, all as set forth in this Agreement. 

          The Company proposes to issue to the underwriter, Paulson Investment Company, Inc. (“Paulson”), in the public
offering of Units referred to above (the “Public Offering”) warrants to purchase up to 120,000 additional Units. 

          The Company wishes to retain the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing so to act, in connection with the issuance, transfer, exchange and replacement
of the certificates evidencing the Unit Warrants to be issued under this Agreement (the “Warrant Certificates”) and the exercise of the Unit Warrants; 

          The Company and the Warrant Agent wish to enter into this Agreement to set forth the terms and conditions of the Unit Warrants and the rights of the holders thereof (“Warrant Holders”) and to set forth the respective rights and obligations of the Company and the Warrant Agent. Each Warrant Holder is an intended beneficiary of this Agreement with
respect to the rights of Warrant Holders herein. 

          NOW, THEREFORE, in consideration of the premises and the mutual agreements herein set forth, the parties hereto agree as follows: 

	
1.          	
Warrants.
    Each Unit Warrant will entitle the registered holder to purchase from the
    Company one share of Common Stock (each a “Share”),
    at $_____ per Share (the “Exercise Price”). The Exercise Price is subject to
adjustments as provided in Section 13 hereof. A Warrant Holder may exercise all or any number of Unit Warrants resulting in the purchase of a whole number of Shares.

	
	 
	
2.	
Exercise Period.
    The Unit Warrants may be exercised at any time during the period (the “Exercise
    Period”)
    commencing ___________, 2009 and ending at 5:00 p.m., Pacific Time on ___________,
    2014 (“Expiration Date”). After the
Expiration Date, any unexercised Unit Warrants will be void and all rights of Warrant Holders shall cease.

	
	 
	
3.	
Execution of Warrant Certificates. Warrant Certificates shall be in registered form only and shall be substantially in the form set forth in Exhibit A attached to this Agreement. Warrant Certificates shall be signed by, or shall bear the facsimile signature of, the President of the Company and the Executive Chairman of the Company and
shall bear a facsimile of the Company’s corporate seal. If any person, whose facsimile signature has been placed upon any Warrant Certificate or the signature of an officer of the Company, shall have ceased to be such officer before such
Warrant Certificate is countersigned, issued and delivered, such Warrant Certificate shall be countersigned, issued and delivered with the same effect as if such person had not ceased to be such officer. Any Warrant Certificate may be signed by, or
made to bear the facsimile signature of, any person who at the actual date of the preparation of such Warrant

	
	 

1

	 	
Certificate shall be a proper officer of the Company to sign such Warrant Certificate even though such person was not such an officer upon the date of the Agreement.

	
	 
	
4.          	
Countersigning. Warrant Certificates shall be manually countersigned by the Warrant Agent and shall not be valid for any purpose unless so countersigned. The Warrant
Agent hereby is authorized to countersign and deliver to, or in accordance with the instructions of, any Warrant Holder any Warrant Certificate which is properly issued.

	
	 
	
5.	
Registration of Transfer and Exchanges. The Warrant Agent shall from time to time register the transfer of any outstanding Warrant Certificate upon records maintained
by the Warrant Agent for such purpose upon surrender of such Warrant Certificate to the Warrant Agent for transfer, accompanied by appropriate instruments of transfer in form satisfactory to the Company and the Warrant Agent and duly executed by the
Warrant Holder or a duly authorized attorney. Upon any such registration of transfer, a new Warrant Certificate shall be issued in the name of and to the transferee and the surrendered Warrant Certificate shall be cancelled.

	
	 
	
6.	
Exercise of Warrants.

	
	 
	 	
(a)          	
Subject to the terms of the Unit Warrant, any Unit Warrant may be exercised upon any single occasion during the exercise period. A Unit Warrant shall be exercised by the Warrant Holder by surrendering to the
Warrant Agent the Warrant Certificate with the exercise form on the reverse of such Warrant Certificate duly completed and executed and delivering to the Warrant Agent, by good check or bank draft payable to the order of the Warrant Agent, the
Exercise Price for each Share to be purchased.

	
	 
	 	
(b)	
Upon receipt of a Warrant Certificate with the exercise form thereon duly executed together with payment in full of the Exercise Price for the Shares for which Unit Warrants are then being exercised, the
Warrant Agent shall requisition from any transfer agent for the Shares, and upon receipt shall make delivery of, certificates evidencing the total number of whole Shares for which Unit Warrants are then being exercised in such names and
denominations as are required for delivery to, or in accordance with the instructions of, the Warrant Holder. Such certificates for the Shares shall be deemed to be issued, and the person whom such Shares are issued of record shall be deemed to have
become a holder of record of such Shares, as of the date of the surrender of such Warrant Certificate and payment of the Exercise Price, whichever shall last occur; provided that if the transfer books of the Company with respect to the Shares, shall
be closed, the certificates for the Shares issuable upon exercise of the Unit Warrants shall be issued as of the date on which such books shall next be open, and the person to whom such Shares are issued of record shall be deemed to have become a
record holder of such Shares as of the date on which such books shall next be open (whether before, on or after the Expiration Date) and until such date the Warrant Agent shall be under no duty to deliver any certificate for such Shares.

	
	 
	 	
(c)	
If less than all a Warrant Holder’s Unit Warrants are exercised upon a single occasion, a new Warrant Certificate for the balance of the Unit Warrants not so exercised shall be issued and delivered to,
or in accordance with, transfer instructions properly given by the Warrant Holder until the Expiration Date.

	
	 
	 	
(d)	
All Warrant Certificates surrendered upon exercise shall be cancelled.

	
	 

2

	 	
(e)	
Upon the exercise of any Unit Warrant, the Warrant Agent shall promptly deposit the payment into an escrow account established by mutual agreement of the Company and the Warrant Agent at a federally insured
commercial bank. All funds deposited in the escrow account will be disbursed on a weekly basis to the Company once they have been determined by the Warrant Agent to be collected funds. Once the funds are determined to be collected, the Warrant Agent
shall cause the Share certificate(s) representing the exercised Unit Warrants to be issued.

	
	 
	 	
(f)	
Expenses incurred by the Warrant Agent will be paid by the Company. These expenses, including delivery of Share certificates to the shareholder, will be deducted from the Exercise Price submitted by a
Warrant Holder prior to the distribution of funds to the Company. A detailed accounting statement relating to the number of Unit Warrants exercised, names and registered Warrant Holder(s) and the net amount of exercised funds remitted will be given
to the Company with the payment of each exercise amount.

	
	 
	
7.          	
Warrant Solicitation and Warrant Solicitation Fee.

	
	 
	 	
(a)          	
The Company has engaged Paulson, on a non-exclusive basis, as its agent for the solicitation of the exercise of the Unit Warrants. The Company will, at its cost, (i) assist Paulson with respect to such
solicitation, if requested by Paulson, and (ii) provide Paulson, and direct the Warrant Agent to deliver to Paulson lists of the record and, to the extent known, beneficial owners of the Company’s Unit Warrants. The Company hereby instructs the
Warrant Agent to cooperate with Paulson in every respect in connection with Paulson’s solicitation activities, including, but not limited to, providing to Paulson, at the Company’s cost, a list of record and beneficial holders of the Unit
Warrants and circulating a prospectus or offering circular disclosing the compensation arrangements referenced in Section 7(b) below to holders of the Unit Warrants at the time of exercise of the Unit Warrants. In addition to the conditions set
forth in Section 7(b), Paulson shall accept payment of the warrant solicitation fee provided in Section 7(b) only if permitted under the rules and regulations of the FINRA and only to the extent that a holder who exercises Unit Warrants specifically
designates, in writing, that Paulson solicited the exercise.

	
	 
	 	
(b)	
In each instance in which a Unit Warrant is exercised, the Warrant Agent shall promptly give written notice of such exercise to the Company and Paulson (“Warrant
Agent’s Exercise Notice”). If, upon the exercise of any Unit Warrant more than one year from the effective date of the registration statement, registering the Unit Warrants, (i) the market price of the
Common Stock is greater than the Exercise Price, (ii) disclosure of compensation arrangements between the Company and Paulson with respect to the solicitation of the exercise of the Unit Warrants was made both at the time of the Public Offering and
at the time of exercise (by delivery of the prospectus or as otherwise required by applicable law, rule or regulation), (iii) the holder of the Unit Warrant confirms in writing that the exercise of the Unit Warrant was solicited by Paulson, (iv) the
Unit Warrant was not held in a discretionary account, and (v) the solicitation of the exercise of the Unit Warrant was not in violation of Regulation M (as such rule or any successor rule may be in effect as of such time of exercise) promulgated
under the Securities Exchange Act of 1934, as amended, then the Warrant Agent, simultaneously with the distribution of the Common Stock underlying the Unit Warrants so exercised in accordance with the instructions from the Company following receipt
of the proceeds to the Company received upon exercise of such Unit Warrant(s), shall, on behalf of the Company, pay a fee of 5% of the Exercise Price to Paulson, provided that Paulson

	
	 

3

	 	
delivers to the Warrant Agent within ten (10) business days from the date on which Paulson has received the Warrant Agent’s Exercise Notice, a certificate that the conditions set forth in the preceding
clauses (iii), (iv) and (v) have been satisfied. Notwithstanding the foregoing, no fee will be paid to Paulson with respect to the exercise by Paulson or its affiliates of Unit Warrants purchased by it or them and still held by it or them for its or
their own account. Paulson and the Company may at any time during business hours, examine the records of the Warrant Agent, including its ledger of original Warrant Certificates returned to the Warrant Agent upon exercise of Unit
Warrants.

	
	 
	 	
(c)	
The provisions of this Section 7 may not be modified, amended or deleted without the prior written consent of Paulson.

	
	 
	
8.          	
Redemption of Warrants.

	
	 
	 	
(a)          	
The Unit Warrants outstanding at the time of a redemption may be redeemed at the option of the Company, in whole or in part on a pro-rata basis, by giving not less than 30 days prior notice as provided in
Section 8(d) below, which notice may not be given before, but may be given at any time after the date on which the closing price of the Common Stock on the principal exchange or trading facility on which it is then traded has equaled or exceeded
$____ for five consecutive trading days.

	
	 
	 	
(b)	
The price at which Unit Warrants may be redeemed (the “Redemption Price”) is $0.003 per Unit Warrant. On and after the
redemption date, the holders of record of redeemed Unit Warrants shall be entitled to payment of the Redemption Price upon surrender of the Warrant Certificates of such redeemed Unit Warrants to the Company at the office of the Warrant
Agent.

	
	 
	 	
(c)	
Notice of redemption of Unit Warrants shall be given at least 30 days prior to the redemption date by mailing, by registered or certified mail, return receipt requested, a copy of such notice to the Warrant
Agent and to all of the holders of record of redeemed Unit Warrants at their respective addresses appearing on the books or transfer records of the Warrant Agent or such other address designated in writing by the holder of record to the Warrant
Agent not less than 40 days prior to the redemption date.

	
	 
	 	
(d)	
From and after the redemption date, all rights of the holders with respect to the redeemed Unit Warrants (except the right to receive the Redemption Price) shall terminate, but only if (i) no later than one
day prior to the redemption date the Company shall have irrevocably deposited with the Warrant Agent as paying agent a sufficient amount to pay on the redemption date the Redemption Price for all Unit Warrants called for redemption and (ii) the
notice of redemption shall have stated the name and address of the Warrant Agent and the intention of the Company to deposit such amount with the Warrant Agent no later than one day prior to the redemption date.

	
	 
	 	
(e)	
On the redemption date, the Warrant Agent shall pay to the holders of record of redeemed Unit Warrants all monies received by the Warrant Agent for the redemption of Unit Warrants to which the holders of
record of such redeemed Unit Warrants who shall have surrendered their Warrant Certificates are entitled. The Warrant Agent shall have no obligation to pay for the redemption of Unit Warrants except to the extent that funds for such payment have
been provided to it by the Company.

	
	 

4

	 	(f)          	All amounts deposited with the Warrant Agent
        that are not required for redemption of Unit Warrants may be withdrawn
        by the Company. Any amounts deposited with the Warrant Agent that shall
        be unclaimed after six months after the redemption date shall be redelivered
        back to the Company, and thereafter the holders of the Unit Warrants
        called for redemption for which such funds were deposited shall look
        solely to the Company for payment, it being understood that the Warrant
        Agent shall be under no obligation to report or remit unclaimed property
        to appropriate states in compliance with applicable law. The Company
        acknowledges that the bank accounts maintained by the Warrant Agent in
        connection with the services hereunder will be in its name and that the
        Warrant Agent may receive investment earnings in connection with the
        investment at the Warrant Agent’s risk and for its benefit of funds
    held in those accounts from time to time. 
	 	 	 
	 	(g)	If the company fails to make a sufficient deposit
        with the Warrant Agent as provided above, the holder of any Unit Warrants
        called for redemption may at the option of the holder (i) by notice to
        the Company declare the notice of redemption a nullity as to such holder,
        or (ii) maintain an action against the Company for the Redemption Price.
        If the holder brings such an action, the Company will pay reasonable
        attorneys’ fees of the holder. If the holder fails to bring an action
        against the Company for the Redemption Price within 60 days after the
        redemption date, the holder shall be deemed to have elected to declare
        the notice of redemption to be a nullity as to such holder and such notice
        shall be without any force or effect as to such holder. Except as otherwise
        specifically provided in this paragraph 8(g), a notice of redemption,
    once mailed by the Company as provided in paragraph 8(c) shall be irrevocable. 
	 	 	 
	 	(h)	Notwithstanding anything to the contrary in
        this Section 8, the Company may not provide notice of any redemption
        pursuant to this Section 8 at any time at which the Warrants are not
        currently exercisable as a result of the application of Section 12. If,
        during the period between notice of redemption and the Redemption Date,
        the Unit Warrants become not currently exercisable as a result of the
        application of Section 12, the Redemption Date shall be extended to be
    the tenth business day after such restriction on exercise lapses. 
	 	 	 
	9.          	Taxes.
        The Company will pay all taxes attributable to the initial issuance of
        Shares upon exercise of Unit Warrants. The Company shall not, however,
        be required to pay any tax which may be payable in respect to any transfer
        involved in any issue of Warrant Certificates or in the issue of any
        certificates of Shares in the name other than that of the Warrant Holder
    upon the exercise of any Unit Warrant.
	 	 
	10.	Mutilated
          or Missing Warrant Certificates.
          On receipt by the Company and the Warrant Agent of evidence satisfactory
          as to the ownership of and the loss, theft, destruction or mutilation
          of any Warrant Certificate, the Company shall execute and the Warrant
          Agent shall countersign and deliver in lieu thereof, a new Warrant
          Certificate. In the case of loss, theft or destruction of any Warrant
          Certificate, the Registered Owner requesting issuance of a new Warrant
          Certificate shall be required to secure an indemnity bond from an approved
          surety bonding company. In the event a Warrant Certificate is mutilated,
          such Warrant Certificate shall be surrendered and canceled by the Warrant
          Agent prior to delivery of a new Warrant Certificate. Applicants for
          a substitute Warrant Certificate shall also comply with such other
          regulations and pay such other reasonable charges as the Warrant Agent
    may prescribe. 
	 	 
	11.	Reservation of Shares.
        For the purpose of enabling the Company to satisfy all obligations to
        issue Shares upon exercise of Unit Warrants, the Company will at all
        times reserve and keep available free from preemptive rights, out of
    the aggregate of its authorized but unissued shares,

5

	 	
the full number of Shares which may be issued upon the exercise of the Unit Warrants and such Shares will upon issue be fully paid and nonassessable by the Company and free from all taxes, liens, charges and
security interests with respect to the issue thereof.

	
	 
	
12.	
Governmental Restrictions. If any Shares issuable upon the exercise of Unit Warrants require registration or approval of any governmental authority, the Company will
use all commercially reasonable efforts to cause such Shares to be duly registered, or approved, as the case may be, and, to the extent practicable, take all such action in anticipation of and prior to the exercise of the Unit Warrants, including,
without limitation, filing any and all post-effective amendments to the Company’s Registration Statement on Form S-1 (Registration No. 333-162345) necessary to permit a public offering of the Shares underlying the Unit Warrants at any and all
times during the term of this Agreement; provided, however, that in no event shall such Shares be issued, and the Company is authorized to refuse to honor the exercise of any Unit Warrant, if such exercise would result in, in the opinion of the
Company’s Board of Directors, upon advice of counsel, in the violation of any law. In the case of a Unit Warrant exercisable solely for securities listed on a securities exchange or for which there are at least three independent market makers,
in lieu of obtaining such registration or approval, the Company may elect to redeem Unit Warrants submitted to the Warrant Agent for exercise for a price equal to the difference between the aggregate low asked price, or closing price, as the case
may be, of the securities for which such Unit Warrant is exercisable on the date of such submission and the Exercise Price of such Unit Warrants. In the event of such redemption, the Company will pay to the holder of such Unit Warrants the
above-described redemption price in cash within 10 business days after receipt of notice from the Warrant Agent that such Unit Warrants have been submitted for exercise. If, at the Expiration Date, the Unit Warrants are not currently exercisable as
a result of the provisions of this paragraph, the Expiration Date shall be extended to a date that is 30 calendar days following notice to the Warrant Holders that the Unit Warrants are again exercisable and references to the Expiration Date herein
shall thereafter refer to such extended Expiration Date.

	
	 
	
13.         	
Adjustments.

	
	 
	 	
(a)          	
If prior to the exercise of any Unit Warrants, the Company shall have effected one or more stock split-ups, stock dividends or other increases or reductions of the number of shares of Common Stock
outstanding without receiving compensation therefor in money, services or property, the number of shares of common stock subject to the Unit Warrants shall (i) if a net increase shall have been effected in the number of outstanding shares of the
Common Stock, be proportionately increased, and the Exercise Price payable per share shall be proportionately reduced, and, (ii) if a net reduction shall have been effected in the number of outstanding shares of the Common Stock, be proportionately
reduced and the Exercise Price payable per share be proportionately increased.

	
	 
	 	
(b)	
In the event of a capital reorganization or a reclassification of the Common Stock (except as provided in Subsection (a) above), any Warrant Holder, upon exercise of the Unit Warrants, shall be entitled to
receive, in substitution for the Common Stock to which he would have become entitled upon exercise immediately prior to such reorganization or reclassification, the shares (of any class or classes) or other securities or property of the Company (or
cash) that he would have been entitled to receive at the same aggregate Exercise Price upon such reorganization or reclassification if such Unit Warrants had been exercised immediately prior to the record date with respect to such event; and in any
such case, appropriate provision (as determined by the Board of Directors of the Company, whose determination shall be conclusive and shall be evidenced by a certified Board resolution filed with the Warrant Agent) shall be made for the application
of this

	
	 

6

	 	 	
Section 13 with respect to the rights and interests thereafter of the Warrant Holders (including but not limited to the allocation of the Exercise Price between or among shares of classes of capital stock),
to the end that this Section 13 (including the adjustments of the number of shares of Common Stock or other securities purchasable and the Exercise Price thereof) shall thereafter be reflected, as nearly as reasonably practicable, in all subsequent
exercises of the Unit Warrants for any shares or securities or other property (or cash) thereafter deliverable upon the exercise of the Unit Warrants.

	
	 
	 	(c)          	
 In case of any consolidation of
    the Company with, or merger of the Company into, another corporation (other
    than a consolidation or merger which does not result in any reclassification
    or change of the outstanding Common Stock), the corporation formed by such
    consolidation or merger shall execute and deliver to the Warrant Agent a
    supplemental warrant agreement providing that the holder of each Unit Warrant
    then outstanding shall have the right thereafter (until the expiration of
    such Unit Warrant) to receive, upon exercise of such Unit Warrant, solely
    the kind and amount of shares of stock and other securities and property
    (or cash) receivable upon such consolidation or merger by a holder of the
    number of shares of Common Stock for which such Units Warrant might have
    been exercised immediately prior to such consolidation, merger, sale or transfer.
    Such supplemental warrant agreement shall provide for adjustments which shall
    be as nearly equivalent as may be practicable to the adjustments provided
    in this Section 13.

	
	 
	
14.         	
Notice to Warrant Holders.
    Upon any adjustment as described in Section 13, the Company within 20 days
    thereafter shall (i) cause to be filed with the Warrant Agent a  certificate
    signed by a Company officer setting forth
    the details of such adjustment, the method of calculation and the facts upon
    which such calculation is based, which certificate shall be conclusive evidence
    of the correctness of the matters set forth therein, (ii) cause written notice
    of such adjustments to be given to each Warrant Holder as of the record date
    applicable to such adjustment. Also, if the Company proposes to enter into
    any reorganization, reclassification, sale of substantially all of its assets,
    consolidation, merger, dissolution, liquidation or winding up, the Company
    shall give notice of such fact at least 20 days prior to such action to all
    Warrant Holders which notice shall set forth such facts as indicate the effect
    of such action (to the extent such effect may be known at the date of such
    notice) on the Exercise Price and the kind and amount of the shares or other
    securities and property deliverable upon exercise of the Unit Warrants. Without
    limiting the obligation of the Company hereunder to provide notice to each
    Warrant Holder, failure of the Company to give notice shall not invalidate
    any corporate action taken by the Company.
	
	 
	
15.	
No Fractional Warrants or Shares. The Company shall not be required to issue fractions of Shares issuable upon exercise of the Unit Warrants, upon the reissue of Unit
Warrants, or any adjustments as described in Section 13 or otherwise; but the Company in lieu of issuing any such fractional interest, shall round up or down to the nearest full Share issuable upon exercise of the Unit Warrant. If the total Unit
Warrants surrendered by exercise would result in the issuance of a fractional share, the Company shall not be required to issue a fractional share but rather the aggregate number of shares issuable will be rounded up or down to the nearest full
share.
	
	 
	
16.	
Rights of Warrant Holders. No Warrant Holder, as such, shall have any rights of a shareholder of the Company, either at law or equity, and the rights of the Warrant
Holders, as such, are limited to those rights expressly provided in the Warrant Certificate. The Company and the Warrant Agent may treat the registered Warrant Holder in respect of any Unit Warrant as the absolute owner thereof for all purposes
notwithstanding any notice to the contrary.
	
	 

7

	
17.         	
Warrant Agent. The Company hereby appoints the Warrant Agent to act as the agent of the Company and the Warrant Agent hereby accepts such appointment upon the
following terms and conditions by all of which the Company and every Warrant Holder, by acceptance of his Warrant Certificates, shall be bound:

	
	 
	 	
(a)          	
Statements contained in this Agreement and in the Warrant Certificate shall be taken as statements of the Company. The Warrant Agent assumes no responsibility for the correctness of any of the same except
such as describes the Warrant Agent or for action taken or to be taken by the Warrant Agent.

	
	 
	 	
(b)	
The Warrant Agent shall not be responsible for any failure of the Company to comply with any of the Company’s covenants contained in this Agreement or in the Warrant Certificates.

	
	 
	 	
(c)	
The Warrant Agent may consult at any time with counsel satisfactory to it (who may be counsel for the Company) and the Warrant Agent shall incur no liability or responsibility to the Company or to any
Warrant Holder in respect of any action taken, suffered or omitted by it hereunder in good faith and in accordance with the opinion or the advice of such counsel, provided the Warrant Agent shall have exercised reasonable care in the selection and
continued employment of such counsel.

	
	 
	 	
(d)	
The Warrant Agent shall incur no liability or responsibility to the Company or to any Warrant Holder for any action taken in reliance upon any notice, resolution, waiver, consent, order, certificate or other
paper, document or instrument believed by it to be genuine and to have been signed, sent or presented by the proper party or parties.

	
	 
	 	
(e)	
The Company agrees to pay to the Warrant Agent reasonable compensation for all services rendered by the Warrant Agent in the execution of this Agreement, to reimburse the Warrant Agent for all expenses,
taxes and governmental charges and all other charges of any kind or nature incurred by the Warrant Agent in the execution of this Agreement and to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments,
costs and counsel fees, for this Agreement except as a result of the Warrant Agent’s gross negligence or bad faith or willful misconduct.

	
	 
	 	
(f)	
The Warrant Agent shall be under no obligation to institute any action, suit or legal proceeding or to take any other action likely to involve expense unless the Company or one or more Warrant Holders shall
furnish the Warrant Agent with reasonable security and indemnity for any costs and expenses which may be incurred in connection with such action, suit or legal proceeding, but this provision shall not affect the power of the Warrant Agent to take
such action as the Warrant Agent may consider proper, whether with or without any such security or indemnity. All rights of action under this Agreement or under any of the Unit Warrants may be enforced by the Warrant Agent without the possession of
any of the Warrant Certificates or the production thereof at any trial or other proceeding relative thereto, and any such action, suit or proceeding instituted by the Warrant Agent shall be brought in its name as Warrant Agent, and any recovery of
judgment shall be for the ratable benefit of the Warrant Holders as their respective rights or interest may appear.

	
	 
	 	
(g)	
The Warrant Agent and any shareholder, director, officer or employee of the Warrant Agent may buy, sell or deal in any of the Unit Warrants or other securities of the Company or become pecuniarily interested
in any transaction in which the Company may

	
	 

8

	 	           	be interested, or contract with or lend money
      to the Company or otherwise act as fully and freely as though it were not
      Warrant Agent under this Agreement. Nothing herein shall preclude the Warrant
      Agent from acting in any other capacity for the Company or for any other
    legal entity.
	 	 
	
18.         	
Successor Warrant Agent. Any corporation into which the Warrant Agent may be merged or converted or with which it may be consolidated, or any corporation resulting
from any merger, conversion or consolidation to which the Warrant Agent shall be a party, or any corporation succeeding to the corporate trust business of the Warrant Agent, shall be the successor to the Warrant Agent hereunder with the same powers,
rights, responsibilities and obligations of the Warrant Agent without the execution or filing of any paper or any further act of a party or the parties hereto. In any such event or if the name of the Warrant Agent is changed, the Warrant Agent or
such successor may adopt the countersignature of the original Warrant Agent and may countersign such Warrants either in the name of the predecessor Warrant Agent or in the name of the successor Warrant Agent.
	
	 
	
19.	
Change of Warrant Agent. The Warrant Agent may resign or be discharged by the Company from its duties under this Agreement by the Warrant Agent or the Company, as the
case may be, giving notice in writing to the other, and by giving a date when such resignation or discharge shall take effect, which notice shall be sent at least 30 days prior to the date so specified. If the Warrant Agent shall resign, be
discharged or shall otherwise become incapable of acting, the Company shall appoint a successor to the Warrant Agent. If the Company shall fail to make such appointment within a period of 30 days after it has been notified in writing of such
resignation or incapacity by the resigning or incapacitated Warrant Agent or after discharging the Warrant Agent, then the Company agrees to perform the duties of the Warrant Agent hereunder until a successor Warrant Agent is appointed. Any
successor Warrant Agent shall be a bank or a trust company, in good standing, organized under the laws of the United States of America, having at the time of its appointment as Warrant Agent, a combined capital and surplus of at least five million
dollars. After appointment, the successor Warrant Agent shall be vested with the same powers, rights, duties and responsibilities as if it had been originally named as Warrant Agent without further act or deed and the former Warrant Agent shall
deliver and transfer to the successor Warrant Agent any property at the time held by it thereunder, and execute and deliver any further assurance, conveyance, act or deed necessary for effecting the delivery or transfer.
	
	 
	 	
Failure to give any notice provided for in the section, however, or any defect therein, shall not affect the legality or validity of the resignation or removal of the Warrant or the appointment of the
successor Warrant Agent, as the case may be.

	
	 
	
20.	
Notices. Any notice or demand authorized by this Agreement to be given or made by the Warrant Agent or by any Warrant Holder to or on the Company shall be sufficiently
given or made if sent by facsimile, mail, first class, certified or registered, postage prepaid, addressed (until another address is filed in writing by the Company with the Warrant Agent), as follows:
	

To the Company: 

BioCurex, Inc. 

7080 River Road, Suite 215 

Richmond, British Columbia, Canada V6X 1X5

Attn: President 

Facsimile: (604) 207-9165 

To the Warrant Agent:

[to be provided] 

9

	 	
Any distribution, notice or demand required or authorized by this Agreement to be given or made by the Company or the Warrant Agent to or on the Warrant Holders shall be sufficiently given or made if sent by
mail, first class, certified or registered, postage prepaid, addressed to the Warrant Holders at their last known addresses as they shall appear on the registration books for the Warrant Certificates maintained by the Warrant Agent.

	
	 
	
21.         	
Supplements and Amendments. The Company and the Warrant Agent may from time to time supplement or amend this Agreement without the approval of any Warrant Holders in
order to cure any ambiguity or to correct or supplement any provisions herein, or to make any other provisions in regard to matters or questions arising hereunder which the Company and the Warrant Agent may deem necessary or desirable.

	
	 
	
22.	
Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company, the Warrant Agent or the registered holders of the Warrant
Certificates shall bind and inure to the benefit of their respective successors and assigns hereunder.

	
	 
	
23.	
Termination. This Agreement shall terminate at the close of business on the Expiration Date or such earlier date upon which all Unit Warrants have been exercised;
provided, however, that if exercise of the Unit Warrants is suspended pursuant to Section 12 and such suspension continues past the Expiration Date, this Agreement shall terminate at the close of business on the business day immediately following
the expiration of such suspension. The provisions of Section 17 shall survive such termination.

	
	 
	
24.	
Governing Law. This Agreement and each Warrant Certificate issued hereunder shall be deemed to be a contract made under the laws of the State of Texas and for all
purposes shall be construed in accordance with the laws of said State.

	
	 
	
25.	
Benefits of this Agreement. Nothing in this Agreement shall be construed to give any person or corporation other than the Company, the Warrant Agent or the registered
holders of the Warrant Certificates any legal or equitable right, remedy or claim under this Agreement.

	
	 
	
26.	
Counterparts. This Agreement may be executed in any number of counterparts, each of such counterparts shall for all purposes be deemed to be an original and all such
counterparts shall together constitute but one and the same instrument.

	
	 

[The remainder of page intentionally left blank]

 

10

          IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed by one of its officers thereunto duly authorized. 

Date: _____________, 2009

BioCurex, Inc. (f/k/a Whispering Oaks International, Inc.)

	
By:   		 
	
Name: Ricardo Moro-Vidal	
	
Title: President and Chief Executive Officer	

Securities Transfer Corporation

	
By:   		 
	
Name:	
	
Title:	

 

11

Exhibit A

VOID AFTER 5 P.M. PACIFIC TIME ON ______________, 2014

UNIT WARRANTS TO PURCHASE COMMON STOCK

	
No. _-________________		
_______________ Unit Warrants	
	 	 
	 		CUSIP _______________

BIOCUREX, INC.

THIS CERTIFIES THAT

 

or registered assigns, is the registered holder of
the number of Unit Warrants (“Warrants”)
set forth above. Each Warrant entitles the  holder thereof to purchase from BioCurex,
Inc. (f’/k/a Whispering Oaks International, Inc.), a corporation incorporated
under the laws of the State of Texas (the “Company”),
subject to the terms and conditions set forth hereinafter and in the Warrant
Agreement between the Company and Securities Transfer Corporation dated ___________,
2009 (the “Warrant Agreement”),
at any time on or after _______________, 2009 and before the close of business
on _______________, 2014 (“Expiration
 Date”), one fully paid and non-assessable
 share of Common Stock, par value $0.001 per share, of the Company (“Common
 Stock”) upon presentation and surrender
 of this Warrant Certificate, with the instructions for the registration and
 delivery of Common Stock filled in, at the stock transfer office located in
 Frisco, Texas of Securities Transfer  Corporation, Warrant Agent of the Company
 (“Warrant Agent”)
 or of its successor warrant agent or, if there be no successor warrant agent,
 at the corporate offices of  the Company, and upon payment of the Exercise Price
 (as defined in the Warrant Agreement) and any applicable taxes paid either in
 cash, or by certified or official bank check, payable in lawful money of the
 United States of America to the order of  the Company. Each Warrant initially
 entitles the holder to purchase one share of Common Stock for $_____. The
 number and kind of securities or other property for which the Warrants are exercisable
 are subject to adjustment in certain events, such as mergers, splits, stock
 dividends, reverse splits and the like, to prevent dilution. The Company may
 redeem any or all outstanding and unexercised Warrants by giving not less than
 30 days prior notice at any time after the date on which the closing price of
 the Common Stock on the principal exchange or trading facility on which it is
 traded has equaled or exceeded $_____ per share on each of five consecutive
trading days. The Redemption Price (as defined in the Warrant Agreement) is $0.003 per Warrant. All Warrants not theretofore exercised will expire on the Expiration Date. 

Exhibit A to Warrant Agreement - Page 1

          This Warrant Certificate is subject to all of the terms, provisions and conditions of the Warrant Agreement, to all of which terms, provisions and conditions the registered holder of this
Warrant Certificate consents by acceptance hereof. The Warrant Agreement is incorporated herein by reference and made a part hereof and reference is made to the Warrant Agreement for a full description of the rights, limitations of rights,
obligations, duties and immunities of the Warrant Agent, the Company and the holders of the Warrant Certificates. Copies of the Warrant Agreement are available for inspection at the stock transfer office of the Warrant Agent or may be obtained upon
written request addressed to the Company at BioCurex, Inc., 7080 River Road, Suite 215, Richmond, British Columbia, Canada V6X 1X5, Attention: Chief Executive Officer. 

The Company shall not be required upon the exercise of the Warrants evidenced by this Warrant Certificate to issue fractions of Warrants, Common Stock or other securities, but shall make adjustment therefor as provided in
the Warrant Agreement. 

In certain cases, the sale of securities by the Company upon exercise of Warrants may violate the securities laws of the United States, certain states thereof or other jurisdictions. The Company has agreed to use all
commercially reasonable efforts to cause a registration statement to continue to be effective during the term of the Warrants with respect to such sales under the Securities Act of 1933, and to take such action under the laws of various states as
may be required to cause the sale of securities upon exercise to be lawful. However, the Company will not be required to honor the exercise of Warrants if, in the opinion of the Board of Directors, upon advice of counsel, the sale of securities upon
such exercise would be unlawful. In certain cases, the Company may, but is not required to, purchase Warrants submitted for exercise for a cash price equal to the difference between the market price of the securities obtainable upon such exercise
and the exercise price of such Warrants. 

This Warrant Certificate, with or without other certificates, upon surrender to the Warrant Agent, any successor warrant agent or, in the absence of any successor warrant agent, at the corporate offices of the Company, may
be exchanged for another Warrant Certificate or certificates evidencing in the aggregate the same number of Warrants as the Warrant Certificate or certificates so surrendered. If the Warrants evidenced by this Warrant Certificate shall be exercised
in part, the holder hereof shall be entitled to receive upon surrender hereof another Warrant Certificate or certificates evidencing the number of Warrants not so exercised. 

No holder of this Warrant Certificate, as such, shall be entitled to vote, receive dividends or be deemed the holder of Common Stock or any other securities of the Company which may at any time be issuable on the exercise
hereof for any purpose whatsoever, nor shall anything contained in the Warrant Agreement or herein be construed to confer upon the holder of this Warrant Certificate, as such, any of the rights of a stockholder of the Company or any right to vote
for the election of directors or upon any matter submitted to stockholders at any meeting thereof or give or withhold consent to any corporate action (whether upon any matter submitted to stockholders at any meeting thereof, or give or withhold
consent to any merger, recapitalization, issuance of stock, reclassification of stock, change of par value or change of stock to no par value, consolidation, conveyance or otherwise) or to receive notice of meetings or other actions affecting
stockholders (except as provided in the Warrant Agreement) or to receive dividends or subscription rights or otherwise until the Warrants evidenced by this Warrant Certificate shall have been exercised and the Common Stock purchasable upon the
exercise thereof shall have become deliverable as provided in the Warrant Agreement. 

If this Warrant Certificate shall be surrendered for exercise within any period during which the transfer

Exhibit A to Warrant Agreement - Page 2

books for the Company’s Common Stock or other class of stock purchasable upon the exercise of the Warrants evidenced by this Warrant Certificate are closed for any purpose, the Company shall not be required to make
delivery of certificates for shares purchasable upon such transfer until the date of the reopening of said transfer books. 

Every holder of this Warrant Certificate by accepting the same consents and agrees with the Company, the Warrant Agent, and with every other holder of a Warrant Certificate that: 

               (a) this Warrant Certificate is transferable on the registry books of the Warrant Agent only upon the terms and conditions set forth in the Warrant Agreement, and 

               (b) the Company and the Warrant Agent may deem and treat the person in whose name this Warrant Certificate is registered as the absolute owner hereof (notwithstanding any notation of ownership
or other writing thereon made by anyone other than the Company or the Warrant Agent) for all purposes whatsoever and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. The Company shall not be required to
issue or deliver any certificate for shares of Common Stock or other securities upon the exercise of Warrants evidenced by this Warrant Certificate until any tax which may be payable in respect thereof by the holder of this Warrant Certificate
pursuant to the Warrant Agreement shall have been paid, such tax being payable by the holder of this Warrant Certificate at the time of surrender. 

This Warrant Certificate shall not be valid or obligatory for any purpose until it shall have been countersigned by the Warrant Agent. 

Exhibit A to Warrant Agreement - Page 3

WITNESS the facsimile signatures of the proper officers of the Company and its corporate seal.

Dated: 

	 		
BIOCUREX, INC.		 	
	 	 	 
	 		
CORPORATE		 	
	-------------------		 		
-------------------	
	
Richard Moro-Vidal		
SEAL		
Dennis Burger	
	-------------------		 		
-------------------	
	 		
TEXAS		 	
	 	 
	PRESIDENT		 	EXECUTIVE CHAIRMAN

 

Countersigned:

SECURITIES TRANSFER CORPORATION

	
By:   		 	
	 		
Authorized Officer	

Exhibit A to Warrant Agreement - Page 4

          The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or
regulations. 

	 	
TEN COM		      	
-- as tenants in common	
	 	 	 	 
	           	
TEN ENT		 		
-- as tenants by the entireties	
	 	 	 	 
	 	
JT TEN		 		
-- as joint tenants with rights of survivorship and not as tenants in common	
	 	 	 	 
	 	
COM PROP		 		
-- as community property	

	
UNIF GIFT MIN ACT          		
--		    	 		    	
Custodian		    	 	
	 		 		 		
(Cust)		 		 		 		
(minor)	
	 	 	 	 	 	 	 	 
	 	 	 	under
    Uniform Gifts to Minors Act	 	 	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 
	 	 	 	(State)	 	 	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 
	
UNIF TRF MIN ACT		
--		 		 		 		
Custodian		 		 	
	 		 		 		
(Cust)		 		 		 		
(minor)	
	 	 	 	 	 	 	 	 
	 
	 	 	 	under Uniform Transfers to Minors
    Act	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	(State)	 	 	 	 

Exhibit A to Warrant Agreement - Page 5

FORM OF EXERCISE 

(To be executed upon exercise of Unit Warrant)

To: BioCurex, Inc.

          The
undersigned, pursuant to the provisions set forth in the within Warrant Certificate,
hereby irrevocably elects to exercise the right of purchase represented thereby,
and hereby agrees to  subscribe for and to purchase shares of the Common Stock
of BioCurex, Inc. (“Common Shares”), as provided for therein, and tenders
herewith payment of the purchase price in full in cash or by wire transfer, check,
draft, money order or  certified or bank cashier’s check in the amount of $___________. 

          Please issue a certificate or certificates for such Common Shares in the name of the undersigned. If the number of Common Shares purchased hereby shall not be all the Common Shares purchasable
under the within Warrant Certificate, a new Warrant Certificate is to be issued in the name of the undersigned for the balance remaining of the Common Shares purchasable thereunder. 

	
Name:		 	
	 		
(Please Print Name and Address)	
	 	
	 	
	
Address:		 	
	 	 
	 	
	 	
	 	
	
Signature(s):          		 	
	 	 
	 		
      Note: This above signature(s) must correspond with
        the name on the face of this Warrant Certificate or with the name of the assignee
    appearing in the assignment form below. 

	 		 
	 		 
	
Date:		 	

Exhibit A to Warrant Agreement - Page 6

FORM OF ASSIGNMENT 

(TO BE SIGNED ONLY UPON ASSIGNMENT)

FOR VALUE RECEIVED, the undersigned Registered Holder
  (_________________________)

  

	 	 
	(Please insert
    social security or other identification number of Registered Holder)
	 
	
hereby sells, assigns and transfers unto	
	 	 
	 	 
	 	 
	 	 
	
(Please Print Name and Address including Zip Code)	

Unit Warrants evidenced by the within Warrant Certificate,
and irrevocably constitutes and appoints _______________________________________
attorney to transfer this Warrant Certificate on the books of BioCurex, Inc.
with the full power of substitution in the premises. 

	
Dated:   		 
	 
	
Signature(s):	
	 
	 
	
      (Signature(s) must conform in all respects to the name
        of Registered Holder as specified on the face of this Warrant Certificate in
        every particular, without alteration or any change whatsoever, and the signature(s)
    must be guaranteed in the usual manner.) 

	 
	 
	Signature(s)
    Guaranteed:
	 
	 
	The signature(s) should
    be guaranteed by an eligible institution (banks, stockbrokers, savings
    and loan association and credit unions with membership in an approved signature
    medallion program), pursuant to S.E.C. Rule 17Ad-15.-- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing

Exhibit 10.3(b)

BioCurex

AMENDMENT TO SEMI-EXCLUSIVE LICENSE AGREEMENT

     THIS AMENDMENT TO SEMI-EXCLUSIVE LICENSE AGREEMENT
(hereinafter, “Agreement”),
effective as of June 1st, 2007 (hereinafter, the “Amendment
Date”), is made by and between Abbott Laboratories, a corporation of
the State of Illinois, having its principal place of business at 100 Abbott Park
Road, Abbott Park, IL 60064-3500 (hereinafter, “Abbott”) and
BioCurex Inc., a corporation of the State of Texas, having its principal place
of business at 215-7080 River Road, Richmond, BC, Canada, V6X 1X5 (hereinafter, “BioCurex”). 

     WHEREAS, the parties hereto entered into a Semi-Exclusive
  License Agreement (the “Agreement”),
  effective as of April 1, 2005, and desire to amend the Agreement as set forth
herein;

      NOW, THEREFORE, in consideration of the mutual promises, covenants and conditions set forth herein, and for other valuable consideration, the receipt and adequacy of which is hereby acknowledged, Abbott and BioCurex hereby amend
the Agreement as follows: 

	
      1.      		
The words “Subject to Section 2.6 below” shall
    be added in Section 2.1 after
    the heading “License.”
	
	 
	
      2.      		
The words “Subject to Section 2.6 below” shall
    be added in Section 2.2 after
    the heading “Exclusive Sublicense Right.”
	
	 
	
      3.      		
The following shall be added to the end of Section 2.5:
	
	 
	 	
The parties hereto recognize the BioCurex has performed certain Research and Development that would have been performed by Abbott under this Section 2.5, and that BioCurex has been reimbursed for the same under
Section 4.2 on the Amendment Date. That Abbott has not performed certain Research and Development under this Section 2.5 prior to the Amendment Date shall not be deemed to be an event of default by Abbott under this Agreement.

	
	 
	
      4.      		
A new Section 2.7 shall be added, as follows:
	
	 
	 	
  2.7      		
Retention of Rights. Notwithstanding anything to the contrary in this Agreement, BioCurex retains the right to:
	
	 
	 	 	
  (a)      		
develop, produce, license, market, sell and distribute (directly or through third parties acting on its behalf) non-automated RECAF microplate assays to third parties with the restriction that they may not automate
or use in conjunction with instrumentation, e.g., automated pippeting apparatus; and
	
	 

	 	 	(b)      	retain all revenues received
          in connection with such activities with no royalties or other payments
          to be made to Abbott by reason thereof;

	 	 	 	 
	 	 	 	and the same shall not be subject
        to any restrictions, including but not limited to any semi-exclusivity
    provisions and limitations, set forth in this Agreement. 
	 	 	 	 
	5.	Except as amended hereby, the
        Agreement is hereby ratified and affirmed and remains in full force and
    effect as of the date hereof. 

     IN WITNESS WHEREOF, each party hereto has caused this Amendment to Semi-Exclusive License Agreement to be executed by its duly authorized representatives as of the Amendment Date. 

	
    Abbott Laboratories		 	  	
      BioCurex Inc.		 
	  
	  
	By:	/s/
      JOSEPH M. NEMMERS, JR. 	 	  	By:	/s/
    RICARDO MORO	 
	Name:	
 Joseph M. Nemmers, Jr.		 	  	Name:	
 Dr. Ricardo Moro		 
	Title:	
 Sr. Vice President,		 	  	Title:	
 President and CEO		 
	 	
       Diagnostic Operations 	 	  	 	  	 
	 	
      President, Diagnostics Division 	 	  	 	  	 

2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00165-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00165-of-00352.parquet"}]]